Regulation of soluble and surface-bound TRAIL in human T cells, B cells, and monocytes.

[1]  J. Lünemann,et al.  Death Ligand TRAIL Induces No Apoptosis but Inhibits Activation of Human (Auto)antigen-Specific T Cells1 , 2002, The Journal of Immunology.

[2]  Arul M. Chinnaiyan,et al.  Molecular Cross-talk between the TRAIL and Interferon Signaling Pathways * , 2001 .

[3]  M. Martínez-Lorenzo,et al.  Differential Secretion of Fas Ligand- or APO2 Ligand/TNF-Related Apoptosis-Inducing Ligand-Carrying Microvesicles During Activation-Induced Death of Human T Cells1 , 2001, The Journal of Immunology.

[4]  Y. Matsuzawa,et al.  Type I interferons and limitin: a comparison of structures, receptors, and functions. , 2001, Cytokine & growth factor reviews.

[5]  P. Vidalain,et al.  Cytotoxic Activity of Human Dendritic Cells Is Differentially Regulated by Double-Stranded RNA and CD40 Ligand1 , 2001, The Journal of Immunology.

[6]  L. Staudt,et al.  Complex immunomodulatory effects of interferon‐β in multiple sclerosis include the upregulation of T helper 1‐associated marker genes , 2001, Annals of neurology.

[7]  Richard A. C. Hughes,et al.  PRISMS-4: Long-term efficacy of interferon-&bgr;-1a in relapsing MS , 2001, Neurology.

[8]  A. Younes,et al.  CD40 ligand (CD154) and tumour necrosis factor‐related apoptosis inducing ligand (Apo‐2L) in haematological malignancies , 2001, British journal of haematology.

[9]  B. Hilliard,et al.  Roles of TNF-Related Apoptosis-Inducing Ligand in Experimental Autoimmune Encephalomyelitis1 , 2001, The Journal of Immunology.

[10]  A. Almasan,et al.  Genomic organization and transcriptional regulation of human Apo2/TRAIL gene. , 2000, Biochemical and biophysical research communications.

[11]  I. Bechmann,et al.  Human brain-cell death induced by tumour-necrosis-factor-related apoptosis-inducing ligand (TRAIL) , 2000, The Lancet.

[12]  M. Weller,et al.  Expression of TRAIL receptors in human autoreactive and foreign antigen-specific T cells , 2000, Cell Death and Differentiation.

[13]  R. Andreesen,et al.  Comparative analysis of CD137 and LPS effects on monocyte activation, survival, and proliferation. , 2000, Biochemical and biophysical research communications.

[14]  S. Strom,et al.  Apoptosis induced in normal human hepatocytes by tumor necrosis factor-related apoptosis-inducing ligand , 2000, Nature Medicine.

[15]  YOUHAI H. Chen,et al.  Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand (Trail) Is an Inhibitor of Autoimmune Inflammation and Cell Cycle Progression , 2000, The Journal of experimental medicine.

[16]  M. Martínez-Lorenzo,et al.  CD59 cross‐linking induces secretion of APO2 ligand in overactivated human T cells , 2000, European journal of immunology.

[17]  Ashkenazi,et al.  Lipopolysaccharide Induces Expression of APO2 Ligand/TRAIL in Human Monocytes and Macrophages , 2000, Scandinavian journal of immunology.

[18]  K. Schooley,et al.  Human Dendritic Cells Mediate Cellular Apoptosis via Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand (Trail) , 1999, The Journal of experimental medicine.

[19]  S. Zhao,et al.  Functional expression of TRAIL by lymphoid and myeloid tumour cells , 1999, British journal of haematology.

[20]  D. Lawrence,et al.  Safety and antitumor activity of recombinant soluble Apo2 ligand. , 1999, The Journal of clinical investigation.

[21]  J. Peschon,et al.  IFN-gamma mediates a novel antiviral activity through dynamic modulation of TRAIL and TRAIL receptor expression. , 1999, Journal of immunology.

[22]  K. Okumura,et al.  Type I Interferons (IFNs) Regulate Tumor Necrosis Factor–related Apoptosis-inducing Ligand (TRAIL) Expression on Human T Cells: A Novel Mechanism for the Antitumor Effects of  Type I IFNs , 1999, The Journal of experimental medicine.

[23]  C. Maliszewski,et al.  Monocyte-mediated Tumoricidal Activity via the Tumor Necrosis Factor–related Cytokine, TRAIL , 1999, The Journal of experimental medicine.

[24]  G. Stark,et al.  How cells respond to interferons. , 1998, Annual review of biochemistry.

[25]  M. Martínez-Lorenzo,et al.  Involvement of APO2 ligand/TRAIL in activation‐induced death of Jurkat and human peripheral blood T cells , 1998, European journal of immunology.

[26]  E. Gelfand,et al.  Requirement for dual signals by anti-CD40 and IL-4 for the induction of nuclear factor-kappa B, IL-6, and IgE in human B lymphocytes. , 1998, Journal of immunology.

[27]  P. Krammer,et al.  Differential regulation of TRAIL and CD95 ligand in transformed cells of the T and B lymphocyte lineage , 1998, European journal of immunology.

[28]  M. Andreeff,et al.  Activity of TNF‐related apoptosis‐inducing ligand (TRAIL) in haematological malignancies , 1997, British journal of haematology.

[29]  C. Smith,et al.  The novel receptor TRAIL-R4 induces NF-kappaB and protects against TRAIL-mediated apoptosis, yet retains an incomplete death domain. , 1997, Immunity.

[30]  J. Torres-Roca,et al.  Interleukin-1β Converting Enzyme–like Protease Involvement in Fas-induced and Activation-induced Peripheral Blood T Cell Apoptosis in HIV Infection. TNF-related Apoptosis-inducing Ligand Can Mediate Activation-induced T Cell Death in HIV Infection , 1997, The Journal of experimental medicine.

[31]  Henning Walczak,et al.  TRAIL‐R2: a novel apoptosis‐mediating receptor for TRAIL , 1997, The EMBO journal.

[32]  W I Wood,et al.  Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors. , 1997, Science.

[33]  Arul M. Chinnaiyan,et al.  The Receptor for the Cytotoxic Ligand TRAIL , 1997, Science.

[34]  C A Smith,et al.  Identification and characterization of a new member of the TNF family that induces apoptosis. , 1995, Immunity.

[35]  E. Podack.  Execution and suicide: cytotoxic lymphocytes enforce Draconian laws through separate molecular pathways. , 1995, Current opinion in immunology.

[36]  I Nicoletti,et al.  A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. , 1991, Journal of immunological methods.

[37]  Kendall A. Smith,et al.  T‐CELL GROWTH FACTOR‐MEDIATED T‐CELL PROLIFERATION * , 1979, Annals of the New York Academy of Sciences.

[38]  M. Greaves,et al.  SELECTIVE TRIGGERING OF HUMAN T AND B LYMPHOCYTES IN VITRO BY POLYCLONAL MITOGENS , 1974, The Journal of experimental medicine.